Back to search
FDAFDA · Food and drugs·Recall number Z-2375-2024

VACUETTE® TUBE 8 ml CAT Serum Separator Clot Activator 16x100 red cap-yellow ring, non-ridged

Published July 24, 2024 · Recall initiated: May 14, 2024

Summary

FDA records medical device Class II recall Z-2375-2024, published July 24, 2024 and initiated May 14, 2024. Recalling firm: Greiner Bio-One North America, Inc.; Status: Ongoing; Reported quantity: 1,008,000pcs (840 cartons); Lot: Item Number: 455071P; UDI Case label: 39120017573068; UDI Rack label: 29120017573061; Lot Number: B24013MV. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The firm received reports that some blood collection tubes have experienced issues with clotting and poor separation due to missing additive. The failure of the device would likely require sample recollection which could result in a delay of treatment.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Greiner Bio-One North America, Inc.
Distributor
Nationwide Distribution to states of: AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WV and WY.
Lot
Item Number: 455071P; UDI Case label: 39120017573068; UDI Rack label: 29120017573061; Lot Number: B24013MV
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was VACUETTE® TUBE 8 ml CAT Serum Separator Clot Activator 16x100 red cap-yellow ring, non-ridged recalled?

Yes. FDA published recall Z-2375-2024 on July 24, 2024. Reported hazard: The firm received reports that some blood collection tubes have experienced issues with clotting and poor separation due to missing additive. The failure of the device would likely require sample recollection which could result in a delay of treatment.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit